ID   APOA4_RAT               Reviewed;         391 AA.
AC   P02651; Q5BK92;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1989, sequence version 2.
DT   02-OCT-2024, entry version 141.
DE   RecName: Full=Apolipoprotein A-IV;
DE            Short=Apo-AIV;
DE            Short=ApoA-IV;
DE   AltName: Full=Apolipoprotein A4;
DE   Flags: Precursor;
GN   Name=Apoa4;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3009456; DOI=10.1016/s0021-9258(19)84575-1;
RA   Boguski M.S., Birkenmeier E.H., Elshourbagy N.A., Taylor J.M., Gordon J.I.;
RT   "Evolution of the apolipoproteins. Structure of the rat apo-A-IV gene and
RT   its relationship to the human genes for apo-A-I, C-III, and E.";
RL   J. Biol. Chem. 261:6398-6407(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=6591177; DOI=10.1073/pnas.81.16.5021;
RA   Boguski M.S., Elshourbagy N.A., Taylor J.M., Gordon J.I.;
RT   "Rat apolipoprotein A-IV contains 13 tandem repetitions of a 22-amino acid
RT   segment with amphipathic helical potential.";
RL   Proc. Natl. Acad. Sci. U.S.A. 81:5021-5025(1984).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3020028; DOI=10.1016/s0021-9258(18)69300-7;
RA   Haddad I.A., Ordovas J.M., Fitzpatrick T., Karathanasis S.K.;
RT   "Linkage, evolution, and expression of the rat apolipoprotein A-I, C-III,
RT   and A-IV genes.";
RL   J. Biol. Chem. 261:13268-13277(1986).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-333, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: May have a role in chylomicrons and VLDL secretion and
CC       catabolism. Required for efficient activation of lipoprotein lipase by
CC       ApoC-II; potent activator of LCAT. Apoa-IV is a major component of HDL
CC       and chylomicrons.
CC   -!- SUBUNIT: Homodimer. {ECO:0000250|UniProtKB:P06727}.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Secreted in plasma.
CC   -!- DOMAIN: Nine of the thirteen 22-amino acid tandem repeats (each 22-mer
CC       is actually a tandem array of two, A and B, related 11-mers) occurring
CC       in this sequence are predicted to be highly alpha-helical, and many of
CC       these helices are amphipathic. They may therefore serve as lipid-
CC       binding domains with lecithin:cholesterol acyltransferase (LCAT)
CC       activating abilities.
CC   -!- SIMILARITY: Belongs to the apolipoprotein A1/A4/E family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M00002; AAA85909.1; -; mRNA.
DR   EMBL; J02588; AAA40747.1; -; Genomic_DNA.
DR   EMBL; M13508; AAA40748.1; -; Genomic_DNA.
DR   EMBL; BC091159; AAH91159.1; -; mRNA.
DR   PIR; A03095; LPRTA4.
DR   RefSeq; NP_036869.1; NM_012737.1.
DR   AlphaFoldDB; P02651; -.
DR   SMR; P02651; -.
DR   IntAct; P02651; 2.
DR   STRING; 10116.ENSRNOP00000069659; -.
DR   iPTMnet; P02651; -.
DR   PhosphoSitePlus; P02651; -.
DR   Ensembl; ENSRNOT00000080658.2; ENSRNOP00000069659.2; ENSRNOG00000055909.2.
DR   Ensembl; ENSRNOT00055033771; ENSRNOP00055027419; ENSRNOG00055019770.
DR   Ensembl; ENSRNOT00060024134; ENSRNOP00060019251; ENSRNOG00060014102.
DR   Ensembl; ENSRNOT00065048152; ENSRNOP00065039531; ENSRNOG00065027936.
DR   GeneID; 25080; -.
DR   KEGG; rno:25080; -.
DR   UCSC; RGD:2132; rat.
DR   AGR; RGD:2132; -.
DR   CTD; 337; -.
DR   RGD; 2132; Apoa4.
DR   GeneTree; ENSGT00950000182929; -.
DR   InParanoid; P02651; -.
DR   OMA; VIWKYFT; -.
DR   OrthoDB; 4637112at2759; -.
DR   PhylomeDB; P02651; -.
DR   Reactome; R-RNO-8963888; Chylomicron assembly.
DR   Reactome; R-RNO-8963901; Chylomicron remodeling.
DR   Reactome; R-RNO-975634; Retinoid metabolism and transport.
DR   PRO; PR:P02651; -.
DR   Proteomes; UP000002494; Chromosome 8.
DR   GO; GO:0009986; C:cell surface; ISO:RGD.
DR   GO; GO:0042627; C:chylomicron; IDA:RGD.
DR   GO; GO:0005615; C:extracellular space; ISO:RGD.
DR   GO; GO:1903561; C:extracellular vesicle; IBA:GO_Central.
DR   GO; GO:0034364; C:high-density lipoprotein particle; ISO:RGD.
DR   GO; GO:0034362; C:low-density lipoprotein particle; IBA:GO_Central.
DR   GO; GO:0045202; C:synapse; IDA:SynGO.
DR   GO; GO:0034361; C:very-low-density lipoprotein particle; ISO:RGD.
DR   GO; GO:0016209; F:antioxidant activity; ISO:RGD.
DR   GO; GO:0120020; F:cholesterol transfer activity; ISO:RGD.
DR   GO; GO:0005507; F:copper ion binding; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0008289; F:lipid binding; ISO:RGD.
DR   GO; GO:0031210; F:phosphatidylcholine binding; ISO:RGD.
DR   GO; GO:0060228; F:phosphatidylcholine-sterol O-acyltransferase activator activity; ISO:RGD.
DR   GO; GO:0005543; F:phospholipid binding; IBA:GO_Central.
DR   GO; GO:0042803; F:protein homodimerization activity; ISO:RGD.
DR   GO; GO:0055090; P:acylglycerol homeostasis; IBA:GO_Central.
DR   GO; GO:0033344; P:cholesterol efflux; ISO:RGD.
DR   GO; GO:0042632; P:cholesterol homeostasis; ISO:RGD.
DR   GO; GO:0008203; P:cholesterol metabolic process; ISO:RGD.
DR   GO; GO:0034375; P:high-density lipoprotein particle remodeling; ISO:RGD.
DR   GO; GO:0042744; P:hydrogen peroxide catabolic process; ISO:RGD.
DR   GO; GO:0002227; P:innate immune response in mucosa; ISO:RGD.
DR   GO; GO:0007159; P:leukocyte cell-cell adhesion; ISO:RGD.
DR   GO; GO:0016042; P:lipid catabolic process; ISO:RGD.
DR   GO; GO:0055088; P:lipid homeostasis; ISO:RGD.
DR   GO; GO:0006869; P:lipid transport; ISO:RGD.
DR   GO; GO:0042157; P:lipoprotein metabolic process; IEA:InterPro.
DR   GO; GO:0034445; P:negative regulation of plasma lipoprotein oxidation; ISO:RGD.
DR   GO; GO:0014012; P:peripheral nervous system axon regeneration; IEP:RGD.
DR   GO; GO:0046470; P:phosphatidylcholine metabolic process; ISO:RGD.
DR   GO; GO:0033700; P:phospholipid efflux; ISO:RGD.
DR   GO; GO:0045723; P:positive regulation of fatty acid biosynthetic process; ISO:RGD.
DR   GO; GO:0010898; P:positive regulation of triglyceride catabolic process; ISO:RGD.
DR   GO; GO:0065005; P:protein-lipid complex assembly; ISO:RGD.
DR   GO; GO:0032374; P:regulation of cholesterol transport; ISO:RGD.
DR   GO; GO:0030300; P:regulation of intestinal cholesterol absorption; ISO:RGD.
DR   GO; GO:0019430; P:removal of superoxide radicals; ISO:RGD.
DR   GO; GO:0032094; P:response to food; TAS:RGD.
DR   GO; GO:0006982; P:response to lipid hydroperoxide; ISO:RGD.
DR   GO; GO:0035634; P:response to stilbenoid; ISO:RGD.
DR   GO; GO:0034014; P:response to triglyceride; IEP:RGD.
DR   GO; GO:0043691; P:reverse cholesterol transport; ISO:RGD.
DR   GO; GO:0034372; P:very-low-density lipoprotein particle remodeling; ISO:RGD.
DR   Gene3D; 1.20.120.20; Apolipoprotein; 2.
DR   InterPro; IPR000074; ApoA_E.
DR   InterPro; IPR050163; Apolipoprotein_A1/A4/E.
DR   PANTHER; PTHR18976; APOLIPOPROTEIN; 1.
DR   PANTHER; PTHR18976:SF1; APOLIPOPROTEIN A-IV; 1.
DR   Pfam; PF01442; Apolipoprotein; 2.
DR   SUPFAM; SSF58113; Apolipoprotein A-I; 1.
PE   1: Evidence at protein level;
KW   Chylomicron; HDL; Lipid transport; Phosphoprotein; Reference proteome;
KW   Repeat; Secreted; Signal; Transport.
FT   SIGNAL          1..20
FT   CHAIN           21..391
FT                   /note="Apolipoprotein A-IV"
FT                   /id="PRO_0000001980"
FT   REPEAT          33..54
FT                   /note="1"
FT   REPEAT          60..81
FT                   /note="2"
FT   REPEAT          82..103
FT                   /note="3"
FT   REPEAT          115..136
FT                   /note="4"
FT   REPEAT          137..158
FT                   /note="5"
FT   REPEAT          159..180
FT                   /note="6"
FT   REPEAT          181..202
FT                   /note="7"
FT   REPEAT          203..224
FT                   /note="8"
FT   REPEAT          225..246
FT                   /note="9"
FT   REPEAT          247..268
FT                   /note="10"
FT   REPEAT          269..286
FT                   /note="11"
FT   REPEAT          287..308
FT                   /note="12"
FT   REPEAT          309..330
FT                   /note="13"
FT   REGION          33..330
FT                   /note="13 X 22 AA approximate tandem repeats"
FT   REGION          354..391
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        376..391
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         333
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   VARIANT         253
FT                   /note="Q -> H"
SQ   SEQUENCE   391 AA;  44456 MW;  24095004A809201D CRC64;
     MFLKAVVLTV ALVAITGTQA EVTSDQVANV MWDYFTQLSN NAKEAVEQLQ KTDVTQQLNT
     LFQDKLGNIN TYADDLQNKL VPFAVQLSGH LTKETERVRE EIQKELEDLR ANMMPHANKV
     SQMFGDNVQK LQEHLRPYAT DLQAQINAQT QDMKRQLTPY IQRMQTTIQD NVENLQSSMV
     PFANELKEKF NQNMEGLKGQ LTPRANELKA TIDQNLEDLR SRLAPLAEGV QEKLNHQMEG
     LAFQMKKNAE ELQTKVSTNI DQLQKNLAPL VEDVQSKLKG NTEGLQKSLE DLNKQLDQQV
     EVFRRAVEPL GDKFNMALVQ QMEKFRQQLG SDSGDVESHL SFLEKNLREK VSSFMSTLQK
     KGSPDQPLAL PLPEQVQEQV QEQVQPKPLE S
//
